Spdr Dow Jones Industrial Average ETF Trust (DIA) recorded net buying of $130.6 million on Thursday, with no shares sold, and increased all 30 of its positions without decreasing any. Within its $45.14 billion portfolio, the largest buys were Goldman Sachs Group ($13.8 million, lifting its weight to 10.53%), Caterpillar ($9.6 million) and Microsoft ($7.9 million). Amgen ($6.8 million) and UnitedHealth Group ($6.1 million) also drew buying. None of the purchases were new positions and there were no sellouts.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
ETFDow JonesGoldman Sachscapital flows
Open a keyword to see other news on the same topic.
Related news
- American Households Own More of the Stock Market Than at Any Time Since the Dot-Com Era
U.S. households directly held $52.12 trillion of U.S. corporate stock on June 30, 2026, a 42.1% share of the $123.69 trillion market and the highest since Q4 1998. Including indirect holdings through pensions and life insurers, their equity total reached $74.03 trillion, a record 48.2% of household financial assets, according to Federal Reserve data released on September 11, 2026. Retail trading volumes have fallen about 20% since mid-summer, yet holdings kept rising through payroll deductions, and Goldman Sachs estimates households bought $840 billion of U.S. stocks in the first half of 2026. The article flags concentration risk, noting NVIDIA was SPY's largest holding at 7.58% as of March 17, 2026, while VTI also includes small and mid-size companies that the S&P 500 leaves out. The next Federal Reserve data release is due December 10, 2026.
- Goldman Sachs Is Paying Up to $2.25 Billion for a $30 Billion ETF Business. Is That Enough to Lift the Stock Back to a Record by 2028?
Goldman Sachs has bid $2.25 billion to acquire privately held NEOS Investments, a covered call ETF specialist. The article argues the deal alone is unlikely to lift the stock back to its July 15 record close of $1,146.65, since the $881.26 close on Oct. 16 would need a 30.1% rally and the company's market value is near $270 billion. Goldman Sachs Asset Management oversees $3.3 trillion, but asset and wealth management brought in just $5.1 billion of the bank's $18.7 billion third-quarter revenue, with investment banking and trading still the main drivers. NEOS's assets have grown from $30 billion at the August announcement to $36.5 billion, and the article calls it a smart acquisition that should pay off over the long term.
- Schwab's Dividend ETF Just Closed at a Record Without Owning a Single "Magnificent Seven" Stock
The Schwab U.S. Dividend Equity ETF (SCHD) closed Thursday, Oct. 22, at $35.40, its highest close ever, surpassing the previous record of $35.21, and is up about 29% since the end of 2025. Over the same stretch, QQQ has fallen about 7% since Oct. 6, while SCHD has risen about 8%. The fund tracks the Dow Jones U.S. Dividend 100 Index, which requires companies to have paid dividends for at least 10 consecutive years, and as of mid-October none of its 102 holdings were 'Magnificent Seven' stocks. As of late September, consumer staples and healthcare made up about 39% of the fund, energy about 15% and tech about 12%. The author argues that over 2023, 2024 and 2025 combined, the fund returned about 22% with dividends versus about 135% for QQQ, so it may lag when big tech leads the market.
- The Dividend ETF Quietly Delivering Double-Digit Returns While Most Investors Aren't Paying Attention
After roughly three years of AI stocks dominating the market, money is starting to rotate into other sectors, and the Schwab U.S. Dividend Equity ETF (SCHD) is up 26% over the past year, excluding dividends. The fund tracks the Dow Jones U.S. Dividend 100 index, keeps technology below 10% of holdings, and is weighted toward healthcare (20.7%), consumer staples (20.4%) and energy (14.1%). The article cites a 3.2% yield, a 0.06% expense ratio, a blended price-to-earnings ratio under 20, and a distribution increase of over 550% since its late 2011 inception. The author suggests the ETF could be a smart portfolio move regardless of what the AI trade does next.
- UnitedHealth Fell 51.32%, Then Rose 40.64%. DIA’s Exposure Followed Both Moves by Design
UnitedHealth (UNH) fell 51.32% from $596.08 on Nov 11, 2024 to $290.17 on May 30, 2025, then rose 40.64% through Oct 15, 2026, though its price remained below the November 2024 level. The article explains that DIA, which tracks the Dow Jones Industrial Average, is price-weighted, so higher-priced stocks take up larger shares of the fund, causing UNH's weight to shrink as its price fell and grow again as it recovered. As of Oct 14, 2026, UNH made up 4.55% of the fund, ranking fifth, while Goldman Sachs (GS) was largest at 10.11%, followed by Caterpillar (CAT) at 8.62% and Microsoft (MSFT) at 6.14%. The author notes this method cushioned losses on the way down but amplified exposure during a sharp rebound, and that weights reflect share price rather than company size or quality. DIA's gross expense ratio is 0.16%, or $16 per $10,000 invested, versus as little as 0.03% for many S&P 500 index funds.
- From Uptober to Hacktober: Are Bitcoin’s seasonal patterns becoming obsolete?
Bitcoin fell 7.3% in October 2026, following a roughly 4% decline a year earlier, according to CoinGlass data, defying the month’s historically bullish “Uptober” reputation. Amid a wave of crypto security incidents, including Binance’s record $6.3 billion hack, industry figures turned to labels such as “Black October” and “Hacktober.” Andrew Yang of Kaiko noted that October has posted Bitcoin’s highest median return at 15.4% and gains in 10 of 13 years through 2025, while Bitcoin’s typical monthly move has shrunk from 14% in 2013–2016 to 9.6% since 2024. Analysts such as Justin d’Anethan of Arctic Digital said ETF flows and corporate buyers are shaped more by liquidity, interest rates and investment mandates than by seasonal narratives, and US spot Bitcoin ETFs recorded $515 million in net outflows in October. Other analysts caution that two losses do not settle the question, as October has generally performed better in bull markets.
Related markets
Latest news
- In the hunt for $1 trillion of revenue, SpaceX reportedly targets Boost Mobile for a deal
The article says there has been intense speculation about SpaceX's ambitions in the cellular market, with multiple acquisition targets suggested. Boost Mobile is the latest of these.
- Gold prices today, Monday, November 2, 2026: Gold opens at its lowest point in over a year ahead of midterms
Gold December futures opened at $3,890 per troy ounce on Monday, down 0.2% from Friday's close, and rose slightly to $3,913.70 by 7:02 a.m. ET. The opening price was the lowest since October 3, 2025, as a sharp equities selloff led investors to sell gold to raise cash, according to Dana Samuelson of American Gold Exchange. He said the gold market was already weak and vulnerable, trading just above its major July support of $3,975, and its break below that level worsened the decline. Compared with a week, a month and a year earlier, the opening price was down 3%, 7.5% and 3.7%, respectively.
- Marvell Plunges 13% on Lumentum Takeover Rumors: Make Your 3-5 Year Bet Right Now
Marvell (MRVL) shares fell 14.05% over the past week to $196.40 after reports of a possible takeover of Lumentum (LITE), and Marvell has issued no official statement. Lumentum's market cap is about $76.2 billion versus about $172.2 billion for Marvell, and the article says a deal would be a heavy lift, possibly requiring new stock or debt on top of $4.96 billion in existing debt. Marvell raised its fiscal 2027 revenue outlook to roughly $12 billion and fiscal 2028 to about $18 billion, and the stock trades at 26x forward earnings. Of 46 analysts covering the stock, 8 rate it Strong Buy, 32 Buy, 6 Hold and none Sell, with a consensus target of $340.56 implying 73.4% upside. Risks cited include reliance on a few hyperscalers and a beta of 2.26, and the fiscal third-quarter report, measured against guidance of $3.15 billion revenue and $1.10 non-GAAP EPS, is the next checkpoint.
- AWS Holds the Scale Crown, Azure Leads the Velocity Charge
AWS and Azure both posted record quarters but are growing in different ways. AWS revenue reached $45.98 billion, up 39%, its sixth straight quarter of faster growth, with a 38.7% operating margin. Azure grew 48%, daily Copilot users rose over 5x, and CFO Amy Hood forecast 49% to 50% constant-currency Azure growth next quarter. Amazon designs its own Trainium chips and plans to sell them outside AWS in late 2027, while Microsoft Cloud gross margin slipped to 66%. Microsoft generated $18.6 billion of free cash flow, while Amazon's trailing free cash outflow reached $42.4 billion.
- Tech stocks enter November after a brutal October: Is it time to buy the dip?
According to the article, both stock and bond markets are raising doubts about whether the AI trade can be sustained after a difficult October for tech stocks.
- Should You Invest $1,000 in BridgeBio Pharma Right Now?
BridgeBio Pharma (BBIO) focuses on rare genetic diseases and has two approved therapies, Attruby and Nulibry, with Attruby accounting for 71% of third-quarter revenue. The article lists three upcoming FDA milestones: a PDUFA date of Nov. 27 for BBP-418, Feb. 4 for oral infigratinib and May 8 for encaleret. Third-quarter total revenue reached $353.2 million, up 193% year over year, including $253.2 million of U.S. net product revenue for Attruby, while the EPS loss narrowed to $0.42 from $0.95. The company reported more than $1.5 billion in cash, nearly 3 times the year-ago level, after closing a $1 billion preferred equity financing. The article acknowledges risks tied to small patient populations but presents three reasons to consider the stock.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.